. 2020 Nov 9;181(3):395–397. doi: 10.1001/jamainternmed.2020.6629

Table 2. Comparison of Attention and Online Engagement Metrics of MedXriv Preprints About COVID-19 Therapies That Were Published and Not Published During the Study Period^a.

Metric	Median (IQR) [range]		P value for difference
Metric	Published (n = 16)	Not published (n = 18)	P value for difference
Altmetric attention score	407.0 (54-3669.8) [1-10 396]	32.0 (11-269.3) [4-7333]	.03
News outlets citing	5 (0-55.3) [0-411.0]	0 (0.0-5.3) [0-130]	.03
Individuals using Twitter	399.0 (43.3-4744.8) [4-11 108]	47.5.0 (15.0-389.8) [9.0-15 131.0]	.06
Citations	11.0 (3.8-28.5) [0-75]	3.5 (1.0-14.0) [0.0-154.0]	.08
Page views	9201.5 (1942-49 077.8) [724-417 105]	1826 (920.3-8950) [427-220 349]	.04

Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range.

^{^a}

For data sources, see the footnote for Table 1. All data are for the preprint article and not for the subsequent publication. All 34 preprints remained posted on medRxiv through July 10, 2020, including the 16 preprints with subsequent publications during the study period. Metrics for the 16 publications are included in the data on publication in Table 1.

Table 2. Comparison of Attention and Online Engagement Metrics of MedXriv Preprints About COVID-19 Therapies That Were Published and Not Published During the Study Perioda.

Table 2. Comparison of Attention and Online Engagement Metrics of MedXriv Preprints About COVID-19 Therapies That Were Published and Not Published During the Study Period^a.